US Stock MarketDetailed Quotes

AVXL Anavex Life Sciences

Watchlist
  • 8.805
  • +0.115+1.32%
Trading Dec 19 12:50 ET
746.62MMarket Cap-17.26P/E (TTM)

Anavex Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.63%-5.85M
-8.50%-7.65M
11.94%-8.49M
-65.50%-5.79M
20.23%-24.24M
47.31%-4.04M
Net income from continuing operations
-8.28%-12.21M
19.54%-10.55M
33.53%-8.62M
0.99%-47.51M
29.00%-10.15M
8.79%-11.28M
-25.57%-13.11M
-19.20%-12.97M
-26.56%-47.98M
-21.95%-14.29M
Other non cash items
----
----
----
--845K
--0
--0
----
----
----
----
Change In working capital
2,027.20%4.61M
-1,809.64%-3.76M
-153.63%-982K
-53.27%2.51M
-73.60%1.11M
-118.03%-239K
94.59%-197K
-47.27%1.83M
859.35%5.36M
371.26%4.2M
-Change in receivables
-19.71%2.07M
63.30%-236K
6.87%-840K
-91.86%484K
-116.13%-543K
2,931.29%2.57M
41.38%-643K
-123.96%-902K
238.65%5.94M
729.25%3.37M
-Change in prepaid assets
84.52%286K
-80.12%-589K
65.78%-103K
-30,000.00%-299K
61.99%174K
5,766.77%155K
-276.97%-327K
-1,249.11%-301K
-98.86%1K
210.01%107.41K
-Change in payables and accrued expense
176.03%2.26M
-479.95%-2.94M
-101.52%-39K
416.27%1.85M
102.65%1.48M
-309.84%-2.97M
131.45%773K
1,049.48%2.56M
-119.15%-584K
-52.13%729.84K
-Change in other working capital
----
----
----
--473K
--0
--0
--0
--473K
----
----
Cash from discontinued investing activities
Operating cash flow
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.63%-5.85M
-8.50%-7.65M
11.94%-8.49M
-65.50%-5.79M
20.23%-24.24M
47.31%-4.04M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-49.46%4.55M
-60.31%7.28M
-77.13%59K
39.29%29.65M
83,341.56%2.06M
30.28%9M
54.90%18.33M
-89.84%258K
-86.11%21.29M
-99.89%2.46K
Net common stock issuance
-51.89%4.11M
----
----
32.83%27.88M
41,554.98%1.19M
29.65%8.53M
----
----
-86.30%20.99M
1,022.83%2.85K
Proceeds from stock option exercised by employees
-5.33%444K
-45.30%99K
-77.13%59K
75.84%1.78M
456,942.11%868K
-8.62%469K
46.65%181K
-30.92%258K
-81.88%1.01M
-100.01%-190
Net other financing activities
----
----
----
----
----
----
----
----
87.26%-707K
98.87%-198
Cash from discontinued financing activities
Financing cash flow
-49.46%4.55M
-60.31%7.28M
-77.13%59K
39.29%29.65M
83,341.56%2.06M
30.28%9M
54.90%18.33M
-89.84%258K
-86.11%21.29M
-99.89%2.46K
Net cash flow
Beginning cash position
-9.18%139.39M
0.10%143.77M
1.25%151.02M
-1.94%149.16M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
-1.94%149.16M
420.05%152.11M
-2.77%153.2M
Current changes in cash
-146.67%-630K
-144.48%-4.38M
-31.12%-7.26M
163.25%1.87M
6.15%-3.79M
1,042.71%1.35M
348.27%9.85M
-475.83%-5.54M
-102.40%-2.95M
25.87%-4.04M
End cash Position
-10.37%138.76M
-9.18%139.39M
0.10%143.77M
1.25%151.02M
1.25%151.02M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
-1.94%149.16M
-1.94%149.16M
Free cash flow
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.63%-5.85M
-8.50%-7.65M
11.94%-8.49M
-65.50%-5.79M
20.23%-24.24M
47.31%-4.04M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 32.31%-5.18M-37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.63%-5.85M-8.50%-7.65M11.94%-8.49M-65.50%-5.79M20.23%-24.24M47.31%-4.04M
Net income from continuing operations -8.28%-12.21M19.54%-10.55M33.53%-8.62M0.99%-47.51M29.00%-10.15M8.79%-11.28M-25.57%-13.11M-19.20%-12.97M-26.56%-47.98M-21.95%-14.29M
Other non cash items --------------845K--0--0----------------
Change In working capital 2,027.20%4.61M-1,809.64%-3.76M-153.63%-982K-53.27%2.51M-73.60%1.11M-118.03%-239K94.59%-197K-47.27%1.83M859.35%5.36M371.26%4.2M
-Change in receivables -19.71%2.07M63.30%-236K6.87%-840K-91.86%484K-116.13%-543K2,931.29%2.57M41.38%-643K-123.96%-902K238.65%5.94M729.25%3.37M
-Change in prepaid assets 84.52%286K-80.12%-589K65.78%-103K-30,000.00%-299K61.99%174K5,766.77%155K-276.97%-327K-1,249.11%-301K-98.86%1K210.01%107.41K
-Change in payables and accrued expense 176.03%2.26M-479.95%-2.94M-101.52%-39K416.27%1.85M102.65%1.48M-309.84%-2.97M131.45%773K1,049.48%2.56M-119.15%-584K-52.13%729.84K
-Change in other working capital --------------473K--0--0--0--473K--------
Cash from discontinued investing activities
Operating cash flow 32.31%-5.18M-37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.63%-5.85M-8.50%-7.65M11.94%-8.49M-65.50%-5.79M20.23%-24.24M47.31%-4.04M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -49.46%4.55M-60.31%7.28M-77.13%59K39.29%29.65M83,341.56%2.06M30.28%9M54.90%18.33M-89.84%258K-86.11%21.29M-99.89%2.46K
Net common stock issuance -51.89%4.11M--------32.83%27.88M41,554.98%1.19M29.65%8.53M---------86.30%20.99M1,022.83%2.85K
Proceeds from stock option exercised by employees -5.33%444K-45.30%99K-77.13%59K75.84%1.78M456,942.11%868K-8.62%469K46.65%181K-30.92%258K-81.88%1.01M-100.01%-190
Net other financing activities --------------------------------87.26%-707K98.87%-198
Cash from discontinued financing activities
Financing cash flow -49.46%4.55M-60.31%7.28M-77.13%59K39.29%29.65M83,341.56%2.06M30.28%9M54.90%18.33M-89.84%258K-86.11%21.29M-99.89%2.46K
Net cash flow
Beginning cash position -9.18%139.39M0.10%143.77M1.25%151.02M-1.94%149.16M1.06%154.82M0.08%153.47M-4.98%143.62M-1.94%149.16M420.05%152.11M-2.77%153.2M
Current changes in cash -146.67%-630K-144.48%-4.38M-31.12%-7.26M163.25%1.87M6.15%-3.79M1,042.71%1.35M348.27%9.85M-475.83%-5.54M-102.40%-2.95M25.87%-4.04M
End cash Position -10.37%138.76M-9.18%139.39M0.10%143.77M1.25%151.02M1.25%151.02M1.06%154.82M0.08%153.47M-4.98%143.62M-1.94%149.16M-1.94%149.16M
Free cash flow 32.31%-5.18M-37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.63%-5.85M-8.50%-7.65M11.94%-8.49M-65.50%-5.79M20.23%-24.24M47.31%-4.04M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+2.44%
Oracle
ORCL
+2.25%
Amazon
AMZN
+1.71%
Netflix
NFLX
+1.47%
Alphabet-A
GOOGL
+1.02%

Unlock the Full List